Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment

In a first study, we performed a cross-sectional analysis of urinary excretion of isoprostanes, IPF2alpha-III and (VI), and monocyte tissue factor (TF) antigen and activity between 11 antiphospholipid (APL) anti body-positive patients and 13 APL negative subjects. In a second study, 11 APL positive patients were randomly supplemented either with (n = 6) or without (it = 5) antioxidants (vitamin E at 900 IU day(-1), vitamin C at 2000 mg day(-1)) for 6 weeks. In a third study, TF and superoxide anion were measured in human monocytes incubated with anti-beta(2) glycoprotein 1 (beta(2)GP(1)) or control IgG, either with or without vitamin E. APL-positive patients had higher values of isoprostanes (P<0.05) and monocyte TF antigen (P=0.001) and activity (P=0.0001) than APL-negative subjects. Only in APL positive patients did monocyte TF antigen correlate significantly with IPF2alpha-III (rho 0.79; P < 0.003) and IPF2alpha-VI (rho= 0.87; P < 0.0001). In patients who received antioxidant supplementation, we found a significant decrease of isoprostanes (P<0.05) and monocyte TF antigen (P<0.01) and activity (P<0.007). In vitro experiments demonstrated that anti-beta(2)GP(1) antibodies dose-dependently enhanced the monocyte production of the superoxide anion and TF, which were significantly inhibited by vitamin E. This study demonstrates that in APL-positive patients, oxidative stress contributes to activate the clotting system via over-expression of monocyte TF. We suggest that anti-beta(2)GP(1) antibodies could play a pivotal role by enhancing the monocyte production of oxygen free radicals.